01 August 2016 2 163 Report

Dear all,

I constructed a mutant 4T1 cell line using CRISPR and implanted it into the 4th mammary gland of BALB/c recently. The tumor grows well at the same rate as WT in the first 12 days but 2 weeks later some of the CRISPR-modified tumor regressed while some remains small about 4~5mm long. I have some guesses but I really need you guy's assitance to help me out.

1. Maybe it's just a good thing, a phenotype. The presence of my gene ruins the immunosurvilence so the mutant cells are attacked and ruled out by the immune cells.

2. The contamination of Mycoplasm. But I think the contaminated cells cannot grow into a tumor at all. I don't have so much experience, so any information about this is appreciated.

3. The loss of cell viability. You know, it takes almost 2 months to finish the entire work of CRISPR. So I am afraid the 4T1 invasiveness will decrease. But for the same reason mentioned in 2, I think if viability is an issue the tumor will not appear at all. I need you guy's help to give me any experiences about this.

Thanks in advance for all your time and kind help, guys!

More Lai Shi's questions See All
Similar questions and discussions